UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 103 filers reported holding UROGEN PHARMA LTD in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,211,720 | – | 372,000 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Horton Capital Management, LLC | 684,749 | $11,517,000 | 23.27% |
| GREAT POINT PARTNERS LLC | 750,000 | $12,615,000 | 2.94% |
| HealthInvest Partners AB | 75,000 | $1,262,000 | 1.89% |
| Wildcat Capital Management, LLC | 533,139 | $8,967,000 | 1.16% |
| Annandale Capital, LLC | 86,254 | $1,451,000 | 0.87% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,954,699 | $49,698,000 | 0.73% |
| ZEKE CAPITAL ADVISORS, LLC | 723,677 | $12,172,000 | 0.70% |
| Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 25,330 | $426,000 | 0.34% |
| RTW INVESTMENTS, LP | 857,464 | $14,423,000 | 0.22% |
| SHIKIAR ASSET MANAGEMENT INC | 33,350 | $561,000 | 0.16% |